{"id":"4ad16fd78e74","type":"article","url":"https://hartvaat.nl/2019/06/04/microvasculaire-ziekte-en-cv-events-bij-diabetes-type-2/","title":"Microvasculaire ziekte en CV-events bij diabetes type 2","title_en":"Influence of Microvascular Disease on Cardiovascular Events in Type 2 Diabetes.","category":"hartfalen","category_label":"Hartfalen","professions":["cardioloog","internist"],"tags":["diabetes-en-hart","diabetes-type-1","diabetes-type-2","ezetimibe","microcirculatie","microvasculaire-angina","ouderen","select-trial","vrouwen"],"journal":"Journal of the American College of Cardiology","doi":"10.1016/j.jacc.2019.03.002","source_url":"https://doi.org/10.1016/j.jacc.2019.03.002","authors":["Subodh Verma","Christoph Wanner","Isabella Zwiener","Anne Pernille Ofstad","Jyothis T George","David Fitchett","Bernard Zinman"],"significance":6,"published":"2019-06-04","source_date":"2019-06-04","image":"","kennis":["https://hartvaat.nl/kennis/farmacologie/glp1-agonisten-cardiologie/"],"congress":"","summary_en":"This study demonstrated that microvascular disease (retinopathy, nephropathy) independently predicts cardiovascular events in type 2 diabetes, supporting microvascular assessment as part of comprehensive cardiovascular risk evaluation.","created":"2026-07-03T10:27:58Z","updated":"2026-07-03T13:27:10Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Studie naar de invloed van microvasculaire ziekte op cardiovasculaire events bij diabetes type 2. Retinopathie en nefropathie als CV-risicomodificatoren.","abstract_original":""}